Michael Freeman
Stock Analyst at Raymond James
(1.89)
Main Sectors:
Top Industries:
6 Stocks
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
WVE WAVE Life Sciences | Assumes: Outperform | 14 | 7.15 | 95.8% | 1 | Jun 11, 2025 | |
TECX Tectonic Therapeutic | Reinstates: Outperform | 76 | 15.24 | 398.69% | 1 | Jun 11, 2025 | |
DYN Dyne Therapeutics | Assumes: Outperform | 37 | 13.06 | 183.31% | 1 | Jun 11, 2025 | |
IRON Disc Medicine | Reinstates: Strong Buy | 89 | 67.78 | 31.31% | 1 | Jun 11, 2025 | |
RNA Avidity Biosciences | Initiates Coverage On: Strong Buy | 65 | 46.97 | 38.39% | 1 | Jun 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Market Perform | 8 | 6.68 | 19.76% | 1 | Jul 10, 2024 |